| 证券代码 | ATRS.O |
| 证券名称 | 安塔尔制药 |
| 证券类型 | 美股 |
| 上市场所 | 纳斯达克交易所 |
| 上市板块 | - |
| 发行方式 | - |
| 首发上市日 | 2012-06-15 |
| 首发价格(元) | - |
| 首发数量(股) | 0 |
| 首发募资额(元) | - |
| 首发主承销商 | - |
| 货币单位 | USD |
| 公司名称 | Antares Pharma, Inc. |
| 注册地址 | 美国特拉华州 |
| 办公地址 | 100 Princeton South, Suite 300, Ewing, New Jersey, USA |
| 成立日期 | 2001-01-31 |
| 董事会主席 | Leonard S. Jacob |
| 公司属地 | United States 美国 |
| 公司网址 | www.antarespharma.com |
| 电话 | +1 (609) 359-3020 |
| 传真 | - |
| 公司简介 | Antares Pharma, Inc. is a specialty pharmaceutical company that combines drug development expertise with proprietary delivery technology to deliver safe and effective medicines. They focus on self-injection, pharmaceutical products and technologies with emphasis in rheumatology, urology, endocrinology, and neurology. Through innovation, Antares Pharma combines pharmaceutical and medical device knowledge to produce treatment options that best serve their patients, physicians, partners, and stakeholders. |